Amelogenesis imperfecta: genes and variants
Explore variant evidence for Amelogenesis imperfecta across 3 analyzed proteins (COL17A1, LAMB3, PRKAR1A). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 13 variants of uncertain significance and 4 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Amelogenesis imperfecta
COL17A1: Collagen alpha-1(XVII) chain
It anchors basal keratinocytes to the basement membrane through hemidesmosomes and is essential for stable epidermal adhesion. Biallelic loss-of-function variants cause junctional epidermolysis bullosa, while autoantibodies against the protein cause bullous pemphigoid.
4 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in COL17A1 have source records linked to Amelogenesis imperfecta. Association strength is not clinical gene validity.
LAMB3: Laminin subunit beta-3
It contributes the beta3 chain of laminin-332, an essential ligand for hemidesmosomal adhesion at the epidermal basement membrane. Biallelic loss-of-function variants cause junctional epidermolysis bullosa, and selected variants can also cause amelogenesis imperfecta.
1 ClinVar pathogenic / likely pathogenic and 12 uncertain variants in LAMB3 have source records linked to Amelogenesis imperfecta. Association strength is not clinical gene validity.
PRKAR1A: cAMP-dependent protein kinase type I-alpha regulatory subunit
It restrains protein kinase A activity in the absence of cyclic AMP and thereby controls a wide range of endocrine and growth signals. Germline loss-of-function variants cause Carney complex, with endocrine overactivity, spotty pigmentation, myxomas, and multiple tumor predispositions.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in PRKAR1A have source records linked to Amelogenesis imperfecta. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): COL7A1 and LAMC2.
ClinVar pathogenic and likely pathogenic variants linked to Amelogenesis imperfecta
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LAMB3 E210K | 210 | Laminin N-terminal | Pathogenic / likely pathogenic (★★) |
| COL17A1 G567E | 567 | Triple-helical region | Pathogenic / likely pathogenic |
| COL17A1 G677D | 677 | Triple-helical region | Pathogenic / likely pathogenic |
| COL17A1 E1199Q | 1199 | Triple-helical region | Pathogenic / likely pathogenic |
| COL17A1 D1200Y | 1200 | Triple-helical region | Pathogenic / likely pathogenic |
Same protein, different disease
- Junctional epidermolysis bullosa also has ClinVar records linked to LAMB3 variants; they fall mostly in different places as the Amelogenesis imperfecta variants (4 pathogenic / likely pathogenic).
Diseases related to Amelogenesis imperfecta
- Junctional epidermolysis bullosa, also linked to COL17A1 and LAMB3
- Junctional epidermolysis bullosa, non-Herlitz, also linked to COL17A1 and LAMB3
- Carney complex, also linked to PRKAR1A
- Junctional epidermolysis bullosa gravis of Herlitz, also linked to LAMB3
- Acrodysostosis 1 with or without hormone resistance, also linked to PRKAR1A
Frequently asked questions
Which genes have records linked to Amelogenesis imperfecta?
This view contains 3 analyzed proteins: COL17A1, LAMB3, PRKAR1A. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 13 variants of uncertain significance and 4 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 46 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center